We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Study Shows Steep Rise in the Use of MRI Scans Before Breast Cancer Surgery

By MedImaging International staff writers
Posted on 09 Oct 2015
Print article
The results of a new study have shown an eightfold rise in the use of Magnetic Resonance Imaging (MRI) scans before breast cancer surgery in the Canadian province of Ontario between 2003 and 2012.

Guidelines on the use of MRI scans before surgery are inconsistent, the study showed, and the increased use of MRI was characteristic of younger, wealthier patients, with a likelihood of additional health problems. The study also found that the use of MRI scans in this context was linked to longer waiting times for surgery and additional testing, and a higher chance of mastectomy, including that of the healthy breast.

The researchers used a large number of healthcare databases in Ontario for the study, and evaluated more than 53,000 women that were diagnosed with breast cancer. The study was published online on September 24, 2015, in the journal JAMA Oncology. The researchers found that only 3% of patients had a preoperative MRI scan in 2003, while in 2012 nearly 24% received an MRI scan. A similar increase was also reported from the US.

MRI scanning is much more expensive than ultrasound, for example, and some of the scans may have been unnecessary. Guidelines for preoperative MRI are and confusing and inconsistent, according to a coauthor of the editorial that accompanied the study, Dr. Constance Lehman, director of breast imaging, Massachusetts General Hospital (Boston, MA, USA).

The study did not show the extent to which the MRI affected clinician’s decisions for further treatment since the medical records used did not indicate whether the results of the MRI scan were positive or negative.

Another coauthor of the study editorial, Dr. Habib Rahbar, University of Washington (Seattle, WA, USA), said, "It is important that we carefully consider how this powerful imaging tool can be used to provide more individualized and targeted therapies to women, rather than not use it altogether."

Related Links:

Massachusetts General Hospital
University of Washington, Seattle


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Dose Calibration Electrometer
PC Electrometer
Imaging Table
Stille imagiQ2
Advanced Cardiac MRI Analysis Software
3Di Cardiac MR

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.